Cart
sales@molnova.com
RAS GTPase inhibitor 1
CAS No. 2252242-32-1
RAS GTPase inhibitor 1( —— )
Catalog No. M33100 CAS No. 2252242-32-1
RAS GTPase inhibitor 1 is a RAS GTPase inhibitor with potential antitumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 567 | Get Quote |
|
| 5MG | 848 | Get Quote |
|
| 10MG | 1159 | Get Quote |
|
| 25MG | 1674 | Get Quote |
|
| 50MG | 2190 | Get Quote |
|
| 100MG | 2790 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRAS GTPase inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionRAS GTPase inhibitor 1 is a RAS GTPase inhibitor with potential antitumor activity.
-
DescriptionRAS GTPase inhibitor 1 (example 51) is a RAS GTPase inhibitor with anti-tumor activity, extracted from patent WO2018212774A1. RAS GTPase inhibitor 1 (example 51) exhibits an EC50 less than 1 μM for at least one nucleotide exchange and an IC50 less than 1 μM in H727 cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorRaf
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2252242-32-1
-
Formula Weight565.99
-
Molecular FormulaC27H28ClF4N5O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(C(O)=O)(F)(F)F.N([C@H](CC)C1CC1)C=2C3=C(C(=CC=C3)C=4CCNCC4)N=C(NC5=CC(Cl)=C(F)C=C5)N2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. WATERSON, Alex G, et al. QUINAZOLINE COMPOUNDS AS MODULATORS OF RAS SIGNALING. Patent. WO2018212774A1.
molnova catalog
related products
-
B-Raf IN 2
B-Raf IN 2, compound Ia, is a highly effective and specific inhibitor of BRAF. It exhibits significant potential for cancer research.
-
L-779450
L-779450 is a potent, ATP-competitive Raf kinase inhibitor with IC50 of 10 nM.
-
R18
Antagonist of 14.3.3 proteins (KD ≈80 nM). Competitively inhibits 14.3.3-ligand interactions without requiring phosphorylation. Blocks the ability of 14.3.3 to bind to target proteins such as Raf-1, Bad, ASK1 and exoenzyme S.
